Novo Integrated Sciences Statistics
Share Statistics
Novo Integrated Sciences has 19.73M
shares outstanding. The number of shares has increased by 3.55%
in one year.
| Shares Outstanding | 19.73M |
| Shares Change (YoY) | 3.55% |
| Shares Change (QoQ) | 3.55% |
| Owned by Institutions (%) | 4.37% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 274.86K, so undefined% of the outstanding
shares have been sold short.
| Short Interest | 274.86K |
| Short % of Shares Out | n/a |
| Short % of Float | 1.57% |
| Short Ratio (days to cover) | 1.13 |
Valuation Ratios
The PE ratio is -0.35 and the forward
PE ratio is null.
Novo Integrated Sciences's PEG ratio is
0.01.
| PE Ratio | -0.35 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/FCF Ratio | -2.48 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Novo Integrated Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37,
with a Debt / Equity ratio of 0.32.
| Current Ratio | 0.37 |
| Quick Ratio | 0.3 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | -0.47 |
| Debt / FCF | -2.05 |
| Interest Coverage | 15.45 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $115,603.1 |
| Profits Per Employee | $-140,248.43 |
| Employee Count | 115 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 7.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is -0.91, so Novo Integrated Sciences's
price volatility has been lower than the market average.
| Beta | -0.91 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 26.93 |
| Average Volume (20 Days) | n/a |
Income Statement
In the last 12 months, Novo Integrated Sciences had revenue of 13.29M
and earned -16.13M
in profits. Earnings per share was -0.89.
| Revenue | 13.29M |
| Gross Profit | 5.74M |
| Operating Income | -10.08M |
| Net Income | -16.13M |
| EBITDA | -10.08M |
| EBIT | -16.78M |
| Earnings Per Share (EPS) | -0.89 |
Full Income StatementBalance Sheet
The company has 844.58K in cash and 4.71M in
debt, giving a net cash position of -3.87M.
| Cash & Cash Equivalents | 844.58K |
| Total Debt | 4.71M |
| Net Cash | -3.87M |
| Retained Earnings | -83.2M |
| Total Assets | 32.14M |
| Working Capital | -9.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -2.24M
and capital expenditures -49.22K, giving a free cash flow of -2.29M.
| Operating Cash Flow | -2.24M |
| Capital Expenditures | -49.22K |
| Free Cash Flow | -2.29M |
| FCF Per Share | -0.13 |
Full Cash Flow StatementMargins
Gross margin is 43.2%, with operating and profit margins of -75.79% and -121.32%.
| Gross Margin | 43.2% |
| Operating Margin | -75.79% |
| Pretax Margin | -121.32% |
| Profit Margin | -121.32% |
| EBITDA Margin | -75.79% |
| EBIT Margin | -75.79% |
| FCF Margin | -17.24% |
